Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Derdeyn

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
AJNR. American Journal of Neuroradiology|May 18, 2023
Advances in Acute Ischemic Stroke Treatment: Current Status and Future DirectionsG Bathla, P Ajmera, P M Mehta, et al.
AJNR. American Journal of Neuroradiology|March 31, 2018
An Update on the Adjunctive Neurovascular Support of Wide-Neck Aneurysm Embolization and Reconstruction Trial: 1-Year Safety and Angiographic ResultsA M Spiotta, M I Chaudry, R D Turner, et al.
Radiology|June 27, 2001
Severe hemodynamic impairment and border zone--region infarctionC P Derdeyn, A Khosla, T O Videen, et al.
AJNR. American Journal of Neuroradiology|October 27, 2018
Hemodynamic Impairment Measured by Positron-Emission Tomography Is Regionally Associated with Decreased Cortical Thickness in Moyamoya PhenomenonJ J Lee, J S Shimony, H Jafri, et al.
Neurology|February 26, 2000
Benign prognosis of never-symptomatic carotid occlusionW J Powers, C P Derdeyn, S M Fritsch, et al.
Radiology|August 3, 1999
Count-based PET method for predicting ischemic stroke in patients with symptomatic carotid arterial occlusionC P Derdeyn, T O Videen, N R Simmons, et al.
AJNR. American Journal of Neuroradiology|May 23, 2020
Preserving Access: A Review of Stroke Thrombectomy during the COVID-19 PandemicT M Leslie-Mazwi, K M Fargen, M Levitt, et al.
Neurology|December 12, 2001
Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic strokeT O Videen, A R Zazulia, E M Manno, et al.
JAMA|October 3, 1998
Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusionR L Grubb, C P Derdeyn, S M Fritsch, et al.
Neurology|March 29, 2006
Frequency of spinal arteriovenous malformations in patients with unexplained myelopathyR G Strom, C P Derdeyn, C J Moran, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
AJNR. American Journal of Neuroradiology|May 18, 2023
Advances in Acute Ischemic Stroke Treatment: Current Status and Future DirectionsG Bathla, P Ajmera, P M Mehta, et al.
AJNR. American Journal of Neuroradiology|March 31, 2018
An Update on the Adjunctive Neurovascular Support of Wide-Neck Aneurysm Embolization and Reconstruction Trial: 1-Year Safety and Angiographic ResultsA M Spiotta, M I Chaudry, R D Turner, et al.
Radiology|June 27, 2001
Severe hemodynamic impairment and border zone--region infarctionC P Derdeyn, A Khosla, T O Videen, et al.
AJNR. American Journal of Neuroradiology|October 27, 2018
Hemodynamic Impairment Measured by Positron-Emission Tomography Is Regionally Associated with Decreased Cortical Thickness in Moyamoya PhenomenonJ J Lee, J S Shimony, H Jafri, et al.
Neurology|February 26, 2000
Benign prognosis of never-symptomatic carotid occlusionW J Powers, C P Derdeyn, S M Fritsch, et al.
Radiology|August 3, 1999
Count-based PET method for predicting ischemic stroke in patients with symptomatic carotid arterial occlusionC P Derdeyn, T O Videen, N R Simmons, et al.
AJNR. American Journal of Neuroradiology|May 23, 2020
Preserving Access: A Review of Stroke Thrombectomy during the COVID-19 PandemicT M Leslie-Mazwi, K M Fargen, M Levitt, et al.
Neurology|December 12, 2001
Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic strokeT O Videen, A R Zazulia, E M Manno, et al.
JAMA|October 3, 1998
Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusionR L Grubb, C P Derdeyn, S M Fritsch, et al.
Neurology|March 29, 2006
Frequency of spinal arteriovenous malformations in patients with unexplained myelopathyR G Strom, C P Derdeyn, C J Moran, et al.
Pageof 8